Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian
  • Portuguese
  • Polish

Breadcrumb

  1. Home
  2. Gastroenterology
  3. SCFAs: new intestinal markers of Parkinson’s disease?
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
Dermatology

Breadcrumb

  1. Home
  2. Gastroenterology
  3. SCFAs: new intestinal markers of Parkinson’s disease?
Gastroenterology

SCFAs: new intestinal markers of Parkinson’s disease?

Parkinson's disease
Gastroenterology Neurology

Short-chain fatty acids (SCFAs) are gut microbiota metabolites already known to be involved in Parkinson’s disease, particularly in rodents. But what about in humans?

Gastroenterology
Gynecology
Pediatrics
Dermatology
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • Mail

About this article

Created 22 April 2022
Updated 02 May 2022

(sidenote: https://parkinsonscare.org.uk/worldparkinsonsday/ ) (April 11) is an opportunity each year for patient associations and health professionals to see how research is progressing on this complex neurodegenerative disease for which there is no treatment to date. This year, discussions will no doubt focus on a new study by a team of Taiwanese researchers. The team wanted to determine whether SCFAs could discriminate between Parkinson’s patients and healthy individuals, and whether there was a correlation with disease severity. To do this, they analyzed plasma and fecal levels of several subtypes of SCFAs in addition to the gut microbiota of 181 participants (96 patients and 85 controls). They also studied the motor and cognitive effects of the disease. The study results were published in Neurology in early 2022.

Different fecal and plasma SCFA levels in Parkinson’s patients 

In Parkinson’s patients, the results showed reduced fecal SCFA levels compared to healthy individuals (butyric acid, valeric acid and propionic acid), whereas plasma levels were higher. 
Another takeaway: fecal quantities of the same SCFAs were lower in patients with advanced Parkinson’s disease compared to patients in the early stages of the disease.

Correlation between SCFA levels and symptom severity 

Fecal and plasma concentrations vary depending on the severity of motor and cognitive symptoms. 

More severe motor impairment is correlated with a low fecal concentration of most SCFAs, coupled with an increased plasma propionic acid concentration.

More serious cognitive symptoms are associated with lower fecal levels of butyric acid and higher plasma concentrations of butyric acid and valeric acid.

Link between the composition of patient microbiota and SCFAs

The study showed that microbial diversity in Parkinson’s patients differed from that in healthy patients. This study highlights the correlation between SCFA concentrations and the abundance of pro-inflammatory bacteria (Clostridiales and Ruminococcus), particularly in the case of propionic acid. This supports the hypothesis that gut inflammation is associated positively with disease aggravation.

Specifically, these results suggest that SCFAs may serve as gut biomarkers for Parkinson’s disease and also reflect severity. This is an interesting scientific advance, which may pave the way for more accurate diagnosis and better patient management.

Sources

Chen SJ, Chen CC, Liao HY, et al. ; Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease. Neurology. 2022 Feb 22;98(8):e848-e858.

Tags
Parkinson SCFA Gut-brain axis

en_view en_sources

    See also

    Actu PRO : Maladie de parkinson : les antibiotiques, et le microbiote, impliqués Role of antibiotics and microbiota in parkinson's disease
    Photo : The gut microbiome and neurodegeneration The gut microbiome and neurodegeneration
    Created 22 April 2022
    Updated 02 May 2022

    About this article

    To know more about this topic.

    Main topic

    Parkinson's disease

    Medical practice

    Gastroenterology Neurology

    Content type

    News
    Gastroenterology

    Your IBS Diagnosis Check List

    How many patients suffering from gut disorder do you see per week? How many are diagnosed with Irritable Bo...

    Find out more

    Everything you need to know about Irritable Bowel Syndrome (IBS)

    Accrediting training, infographics, expert’s video, thematic folder, news… Biocodex Microbiota Institute pr...

    Find out more

    Gut Microbiota #17

    By Pr. Satu PekkalaAcademy of Finland Research Fellow, Faculty of Sport and Health Sciences, University of ...

    Find out more

    Impact of beer and non alcoholic comsumption on the gut microbiota

    By Pr. Bernd SchnablDivision of Gastroenterology, San Diego Digestive Diseases Research Center (SDDRC), UC ...

    Find out more

    Gut Microbiota # 16

    By Pr. Satu PekkalaAcademy of Finland Research Fellow, Faculty of Sport and Health Sciences, University of ...

    Find out more

    Highlights from the UEGW

    By Dr. Lucas WautersGastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium

    Find out more

    The Gut-Brain axis

    By Pr. Sarkis K. Mazmanian, John W. Bostick, Nadia SuryawinataBiology and Biological Engineering, Californi...

    Find out more

    Human milk nutrient fortifiers alter the developing gastrointestinal microbiota of very-low-birth-weight infants

    Commented article - Children's section By Pr. Emmanuel M...

    Find out more

    Continue reading

    News
    30.01.2023

    Schizophrenia and aggressive behavior: what involvement of the intestinal microbiota?

    Read the article
    23.01.2023

    Idiopathic urethritis in men: new infectious etiologies?

    Read the article
    13.01.2023

    Insomnia in seniors: a link with the gut microbiota

    Read the article
    03.01.2023

    Almonds: limited effects on the gut microbiota

    Read the article
    14.12.2022

    Microplastics in takeaway food put gut and oral flora at risk

    Read the article
    16.12.2022

    Does the gut microbiota influence vaccine efficacy?

    Read the article
    05.12.2022

    Can gut bacteria and metabolites help the earlier prediction of necrotizing enterocolitis in newborns?

    Read the article
    Photo: WAAW 2022 (HCPs)
    25.10.2022

    Microbiota at the forefront of antibiotic resistance

    Read the article
    What's worth reading about microbiota
    Follow us on Twitter
    Read our thematic folder
    The Janus face of Antibiotics: Life Savers & Microbiota Disrupters
    NL13_cover
    Check out latest newsletter
    IBS, Microbiota & Covid-19
    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology
    • English
    • Français
    • Español
    • Russian
    • Portuguese
    • Polish

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    30.01.2023

    Schizophrenia and aggressive behavior: what involvement of the intestinal microbiota?

    Read the article
    23.01.2023

    Idiopathic urethritis in men: new infectious etiologies?

    Read the article

    Impact of beer and non alcoholic comsumption on the gut microbiota

    By Pr. Bernd SchnablDivision of Gastroenterology, San Diego Digestive Diseases Research Center (SDDRC), UC ...

    Find out more

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    © 2022 Biocodex. All rights reserved.

    • Cookies Policy
    • Data protection policy
    • GTU
    • Sitemap
    • Cookies settings
    Biocodex logo